Catheter-directed thrombolysis: is it worth the risk?

Affiliations

¹ Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: zack.chad@mayo.edu.
² Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
³ Division of Cardiovascular Diseases, Temple University School of Medicine, Philadelphia, PA, USA.

Comment

Chad J Zack et al. Lancet Haematol. 2016 Feb.

. 2016 Feb;3(2):e54-5.

doi: 10.1016/S2352-3026(15)00287-2. Epub 2016 Jan 6.

¹ Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: zack.chad@mayo.edu.
² Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
³ Division of Cardiovascular Diseases, Temple University School of Medicine, Philadelphia, PA, USA.

No abstract available

Comment on

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.
Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group. Haig Y, et al. Lancet Haematol. 2016 Feb;3(2):e64-71. doi: 10.1016/S2352-3026(15)00248-3. Epub 2016 Jan 6. Lancet Haematol. 2016. PMID: 26853645 Clinical Trial.